Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy

Marta Boffito, Edward Acosta, David Burger, Courtney V. Fletcher, Charles Flexner, Rodolphe Garaffo, Giorgio Gatti, Michael Kurowski, Carlo Federico Perno, Gilles Peytavin, Mario Regazzi, David Back

Research output: Contribution to journalArticle

Abstract

The consensus of current international guidelines for the treatment of HIV infection is that data on therapeutic drug monitoring (TDM) of non-nucleoside reverse transcriptase inhibitors and protease inhibitors provide a framework for the implementation of TDM in certain defined scenarios in clinical practice. However, the utility of TDM is considered to be on an individual basis until more data are obtained from large clinical trials showing the benefit of TDM. In April 2004, a panel of experts met in Rome, Italy. This followed an inaugural meeting in Perugia, Italy, in October 2000, which resulted in the article published in AIDS 2002, 16(Suppl 1):S5-S37. The objectives of this second meeting were to review the questions surrounding TDM of antiretroviral drugs and discuss the clinical utility, current concerns and future prospects of drug concentration monitoring in the care of HIV-1-infected individuals. This report, which has been updated to include material published or presented at international conferences up to the end of September 2004, reviews pharmacokinetic and pharmacodynamic data and reports the issues discussed by the panel, offering advice to clinical care providers who may be currently, or are considering incorporating TDM into the routine care of their patients. In addition, the panel formulated a series of position statements that are relevant to the interpretation of current data and can aid the design of future clinical trials.

Original languageEnglish
Pages (from-to)375-392
Number of pages18
JournalAntiviral Therapy
Volume10
Issue number3
Publication statusPublished - 2005

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy'. Together they form a unique fingerprint.

  • Cite this

    Boffito, M., Acosta, E., Burger, D., Fletcher, C. V., Flexner, C., Garaffo, R., Gatti, G., Kurowski, M., Perno, C. F., Peytavin, G., Regazzi, M., & Back, D. (2005). Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy. Antiviral Therapy, 10(3), 375-392.